Susan Galbraith, Executive Vice President of Oncology Research & Development at AstraZeneca — Verified Quotes & Interview Transcripts

Recent appearances

New FDA Approvals For Breast Cancer Drugs Signal 'Exciting' Oncology Progress: AstraZeneca R&D Chief

June 03, 2026 · 📺 Forbes Breaking News

Over the last several weeks, AstraZeneca has received a series of FDA approvals for drugs treating breast cancer. It marks a potentially new phase in understanding this devastating disease. Susan Galbraith, head of oncology R&D at AstraZeneca, joined Forbes senior editor Maggie McGrath to discuss the treatments that were approved and what they mean for patients with breast cancer. "The opportunity to make transformational change in cancer has never been more possible," Galbraith says. Stay Connected Forbes Breaking News on X: https://x.com/ForbesTVNews Forbes Breaking News on TikTok: / forb…

Watch on YouTube ↗
Creating Breakthroughs in Oncology: A Conversation with Susan Galbraith of AstraZeneca

May 26, 2025 · 📺 IDEA Pharma

In this episode of IDEA Collider, we sit down with Susan Galbraith from AstraZeneca, a leading figure in oncology R&D. Susan shares her journey from medical training in Manchester and Cambridge to spearheading transformative cancer treatments at AstraZeneca. She discusses pivotal moments in her career, AstraZeneca's vision for eliminating cancer as a cause of death, the role of patient stories in motivating R&D efforts, and the integration of emerging technologies like AI and digital health tools. With a focus on collaboration and continuous learning, Susan provides insights into how success…

Watch on YouTube ↗
THE Osler lecture Cancer therapy development in 2030 - emerging trends and novel modalities

May 13, 2025 · 📺 AoPGBI

The Osler Lecture from APAM 2025 Presented by Dr. Susan Galbraith EVP Oncology Haematology R&D, AstraZeneca In this insightful lecture, Dr. Susan Galbraith highlights five key trends that have the potential to significantly transform cancer care: Novel Antibody-Drug Conjugates and Radioconjugates: Enhancing chemotherapy and radiotherapy regimens with innovative antibody-drug conjugates and radioconjugates. Segmentation of the Immuno-Oncology (IO) Space: Advancing beyond current immune checkpoint inhibitors and exploring the next generation of bispecific IO agents to better target the IO-sen…

Watch on YouTube ↗
Career advice for women in the workplace

May 16, 2024 · 📺 astrazeneca

“In Conversations with…” is an internal podcast led by our CFO, Aradhana Sarin to spotlight women who are thought leaders in their industry, the secrets of their success as well as their views on the challenges -- and opportunities -- that affect women in the workplace. We’re sharing a special episode where Aradhana is joined by members of our Senior Executive Team, as they discuss their careers, their influences and gender equality at work. Panel Guests Sharon Barr, EVP Biopharmaceuticals R&D Pam Cheng, EVP Global Operations & IT, Chief Sustainability Officer Susan Galbraith, EVP Oncolo…

Watch on YouTube ↗
Susan Galbraith: Driving innovation in cancer research

April 25, 2024 · 📺 astrazeneca

Susan Galbraith, EVP, Oncology R&D discusses her career journey, our Oncology R&D strategy to transform cancer outcomes, advice for the next generation of STEM leaders, and what makes us a Great Place to Work. Learn more about Susan Galbraith: https://www.astrazeneca.com/our-compa... How did you get to this point in your career – 00:00 – 01:16 What do you think makes our Oncology R&D strategy stand apart – 01:17 – 03:29 What does it mean to you being in this role – 03:30 – 04:24 Beyond your core roles & responsibilities, what other passions do you have at AstraZeneca – 04:25 – 05:33 What ad…

Watch on YouTube ↗
AstraZeneca: Fusion acquisition will be a cost effective-investment that can improve cancer outcomes

March 19, 2024 · 📺 CNBC International Live

Dr. Susan Galbraith, executive vice-president of oncology and R&D at AstraZeneca, discusses the healthcare giant's $2.4bn acquisition of Fusion Pharmaceuticals.

Watch on YouTube ↗
Susan Galbriath on Cancer Research and New Medicines: Inaugural Ruth Lynden-Bell Lecture and Panel

February 19, 2024 · 📺 Murray Edwards College, University of Cambridge

Murray Edwards College was delighted to host Dr Susan Galbraith, Executive Vice-President, Oncology R&D, AstraZeneca, as our first featured speaker in the Professor Ruth Lynden-Bell Lecture series. Dr Galbraith’s talk was followed by a panel discussion chaired by Dr Kristin-Anne Rutter, Murray Edwards alumna and Executive Director of Cambridge University Health Partners, and featuring Dr Bristi Basu and Kevin Lee, CEO of Bicycle Therapeutics.

Watch on YouTube ↗
Q3 2021 financial results: Susan Galbraith and Mene Pangalos

November 11, 2021 · 📺 astrazeneca

Our continued scientific advancements are driven by our commitment to help patients worldwide. See our full Q3 2021 financial highlights: https://www.astrazeneca.com/media-cen... ------------------------------------------------------------ Global site: https://www.astrazeneca.com/ Careers site: https://careers.astrazeneca.com/ Follow us: Twitter: / astrazeneca LinkedIn: / astrazeneca Instagram: / astrazeneca Facebook: / astrazeneca

Watch on YouTube ↗
Exploring Advancements in Oncology with AstraZeneca’s Dr. Susan Galbraith

April 06, 2021 · 📺 PharmaVoice

PharmaVOICE sat down with Dr. Susan Galbraith, SVP of Early Oncology, AstraZeneca, who disclosed her personal career journey with oncology and drug development as she works to improve patients’ lives.

Watch on YouTube ↗
Dr. Susan Galbraith

March 30, 2021 · 📺 WoW - PharmaVOICE Woman of the Week

Dr. Susan Galbraith, Senior VP of Early Oncology, AstraZeneca, discusses her personal career journey with oncology and drug development as she works to improve patients’ lives as well as her passion for paying it forward.

Watch on YouTube ↗
Care for Cancer, Dr. Susan Galbraith, AstraZeneca

December 19, 2018 · 📺 Uppsala Health Summit

Plenum Session: A Visionary Outlook.

Watch on YouTube ↗
Susan Galbraith at One Nucleus' ON Helix Conference

March 23, 2017 · 📺 OneNucleus

Susan Galbraith, VP and Head of Oncology, iMed, AstraZeneca, on how industry, academia and government can work together ...

Watch on YouTube ↗

Other executives at AstraZeneca

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →

Recent appearances

Other executives at AstraZeneca

Keep reading the full archive